These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22641271)

  • 1. How do guidelines impact measures of performance? Can they keep up?
    Handberg E
    Arch Intern Med; 2012 Jun; 172(12):945-6. PubMed ID: 22641271
    [No Abstract]   [Full Text] [Related]  

  • 2. Is hypertension overtreatment a silent epidemic?
    Rosansky S
    Arch Intern Med; 2012 Dec; 172(22):1769; author reply 1770. PubMed ID: 23229941
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry
    Arnold SV; Goyal A; Inzucchi SE; McGuire DK; Tang F; Mehta SN; Sperling LS; Maddox TM; Einhorn D; Wong ND; Hammar N; Fenici P; Khunti K; Lam CSP; Kosiborod M
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of interval based quality indicators in blood pressure management to enhance quality of pay for performance incentives: comparison to two indicators from the Quality and Outcomes Framework.
    Mabotuwana T; Warren J; Elley CR; Kennelly J; Paton C; Warren D; Chang Wai K; Wells S
    Qual Prim Care; 2010; 18(2):93-101. PubMed ID: 20529470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of diabetes and hypertension: how do primary care physicians judge their performance?].
    Krause P; Wittchen HU; Küpper B; Pittrow D; Unger T; Sharma AM; Ritz E; Göke B; Lehnert H; Tschöpe D; Kirch W; Pfister H; Bramlage P; Höfler M
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():12-8. PubMed ID: 14732945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [beta-blockers in the treatment of hypertension in diabetic patients].
    Kobusiak-Prokopowicz M
    Pol Merkur Lekarski; 2004 Apr; 16(94):389-93. PubMed ID: 15517941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do changes to Quality and Outcomes Framework diabetes clinical indicators affect care as measured in the National Diabetes Audit?
    Gadsby R; Young B
    Diabet Med; 2016 Dec; 33(12):1748-1749. PubMed ID: 27480408
    [No Abstract]   [Full Text] [Related]  

  • 8. Might losartan reduce sudden cardiac death in diabetic patients with hypertension?
    Aronow WS
    Lancet; 2003 Aug; 362(9384):591-2. PubMed ID: 12944056
    [No Abstract]   [Full Text] [Related]  

  • 9. Socioeconomic inequalities in indicator scores for diabetes: poor quality or poor measures?
    Shekelle PG
    BMJ; 2004 Nov; 329(7477):1269-70. PubMed ID: 15548560
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of recent papers in hypertension. Post menopausal hormone replacement therapy prevents diabetes.
    Basile J
    J Clin Hypertens (Greenwich); 2003; 5(5):353-4. PubMed ID: 14696584
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological treatment of hypertension].
    Nikkilä M
    Duodecim; 1999; 115(8):959-62, 965-9. PubMed ID: 11859530
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence, awareness, treatment, and control of hypertension among Canadian adults with diabetes, 2007 to 2009.
    Gee ME; Janssen I; Pickett W; McAlister FA; Bancej CM; Joffres M; Johansen H; Campbell NR
    Can J Cardiol; 2012 May; 28(3):367-74. PubMed ID: 22281410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypertension, diabetes mellitus and comorbidity in primary care].
    Wittchen HU; Krause P; Höfler M; Pfister H; Ritz E; Göke B; Lehnert H; Tschöpe D; Kirch W; Pittrow D; Sharma AM; Bramlage P; Küpper B; Unger T
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():19-27. PubMed ID: 14732946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, awareness and management of hypertension in Cameroon: findings of the 2003 Cameroon Burden of Diabetes Baseline Survey.
    Kamadjeu RM; Edwards R; Atanga JS; Unwin N; Kiawi EC; Mbanya JC
    J Hum Hypertens; 2006 Jan; 20(1):91-2. PubMed ID: 16163363
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus.
    Johnson ML; Parikh N; Kunik ME; Schulz PE; Patel JG; Chen H; Aparasu RR; Morgan RO
    Alzheimers Dement; 2012 Sep; 8(5):437-44. PubMed ID: 22521970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for development of diabetes mellitus, hypertension and dyslipidemia.
    Fukui M; Tanaka M; Toda H; Senmaru T; Sakabe K; Ushigome E; Asano M; Yamazaki M; Hasegawa G; Imai S; Nakamura N
    Diabetes Res Clin Pract; 2011 Oct; 94(1):e15-8. PubMed ID: 21802759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The issue of noncompliance.
    Navarro RP
    Med Interface; 1996 Aug; 9(8):70, 72. PubMed ID: 10159579
    [No Abstract]   [Full Text] [Related]  

  • 18. Does the PPAR-γ-activating property of telmisartan provide a benefit in clinical practice?
    Fujimura A; Ushijima K; Ando H
    Hypertens Res; 2013 Feb; 36(2):183. PubMed ID: 23190691
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot quality improvement intervention in patients with diabetes and hypertension in primary care settings of Cyprus.
    Samoutis GA; Soteriades ES; Stoffers HE; Philalithis A; Delicha EM; Lionis C
    Fam Pract; 2010 Jun; 27(3):263-70. PubMed ID: 20348163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of self-reporting of diabetes mellitus and hypertension and its determinants among Omani adults.
    Al-Riyami AA; Afifi MM
    Saudi Med J; 2003 Sep; 24(9):1025-6. PubMed ID: 12973495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.